These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 399652)

  • 1. A review of the renin-angiotensin system: historical and methodological perspectives.
    Moore AF
    Methods Find Exp Clin Pharmacol; 1979 Apr; 1(1):23-44. PubMed ID: 399652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renin 1978.
    Peart WS
    Johns Hopkins Med J; 1978 Dec; 143(6):193-206. PubMed ID: 364155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacology of SC-52458, an orally active, nonpeptide angiotensin AT1 receptor antagonist.
    Olins GM; Corpus VM; Chen ST; McMahon EG; Palomo MA; McGraw DE; Smits GJ; Null CL; Brown MA; Bittner SE
    J Cardiovasc Pharmacol; 1993 Oct; 22(4):617-25. PubMed ID: 7505365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptides as targets for antihypertensive drug development.
    Hedner T; Sun X; Junggren IL; Pettersson A; Edvinsson L
    J Hypertens Suppl; 1992 Dec; 10(7):S121-32. PubMed ID: 1291647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular reactivity to angiotensin in borderline hypertension.
    Safar M; London G; Weiss Y; Simon A; Milliez P
    Biomedicine; 1974 Dec; 21(12):491-4. PubMed ID: 4376972
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of brain renin-angiotensin on cardiovascular function and saline intake in awake dogs.
    Buckley JP; Jandhyala BS; Doursout MF; Huang YK; Chelly JE
    J Physiol (Paris); 1984; 79(6):485-90. PubMed ID: 6399316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonism between the vascular renin-angiotensin and natriuretic peptide systems in vascular remodelling.
    Itoh H; Nakao K
    Blood Press Suppl; 1994; 5():49-53. PubMed ID: 7534179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonists, inhibitors and antisera in the evaluation of vascular renin activity. The role of local generation of angiotensin II.
    Swales JD
    Prog Biochem Pharmacol; 1976; 12():98-113. PubMed ID: 798204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of saralasin to evaluate the function of the brain renin-angiotensin system.
    Reid IA
    Prog Biochem Pharmacol; 1976; 12():117-34. PubMed ID: 1019160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ureteral function is modulated by a local renin-angiotensin system.
    Santis WF; Peters CA; Yalla SV; Sullivan MP
    J Urol; 2003 Jul; 170(1):259-63. PubMed ID: 12796700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The endocrine control of blood volume, blood pressure and sodium balance: atrial hormone and renin system interactions.
    Laragh JH
    J Hypertens Suppl; 1986 Jun; 4(2):S143-56. PubMed ID: 2941538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Activation of the renin-angiotensin system and blood pressure variability in rats].
    Blanc J; Lambert G; Elghozi JL
    Arch Mal Coeur Vaiss; 2000 Aug; 93(8):1019-22. PubMed ID: 10989749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The place of renin in the mechanism of hypertension in chronic renal disease.
    Peart WS
    Clin Nephrol; 1975 Oct; 4(4):138-43. PubMed ID: 1104233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo effects of angiotensin II on vascular smooth muscle contraction and blood pressure are mediated through a protein tyrosine-kinase-dependent mechanism.
    Sauro MD; Sudakow R; Burns S
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1744-50. PubMed ID: 8667246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of renin as a blood-borne hormone tested by infusion of renin inhibitor (H.77).
    Tree M; Fraser R; Holloway C; Hughes M; Ingram M; Leckie BJ; Lever AF; Morton JJ; Szelke M
    Kidney Int Suppl; 1988 Sep; 25():S33-7. PubMed ID: 3054239
    [No Abstract]   [Full Text] [Related]  

  • 16. The intracellular renin-angiotensin system: a new paradigm.
    Kumar R; Singh VP; Baker KM
    Trends Endocrinol Metab; 2007 Jul; 18(5):208-14. PubMed ID: 17509892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of aortic and cardiac AT1 receptor gene expression in transgenic (mRen-2) 27 rats.
    Nickenig G; Laufs U; Schnabel P; Knorr A; Paul M; Böhm MP
    Br J Pharmacol; 1997 May; 121(1):134-40. PubMed ID: 9146897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interrelation of coronary effects of atrial natriuretic peptide and the renin-angiotensin system in the isolated perfused rat heart.
    Bauer WR; Neubauer S; Obitz G; Ertl G
    J Mol Cell Cardiol; 1994 Apr; 26(4):527-37. PubMed ID: 8072008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Actions of angiotensin II on the renal microvasculature.
    Arendshorst WJ; Brännström K; Ruan X
    J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S149-61. PubMed ID: 9892156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.